I V Specialties Inc is categorized under Infectious Disease Specialists in Sarasota, FL and active since 1982.
I V Specialties Inc was established in 1982, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Infectious Disease Specialists business, which does work in the B2C market, and is classified as a Infectious Disease Specialists, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Andrew Krinsky at the company’s single location by writing to 1425 South Osprey Avenue # 1, Sarasota, Florida FL 34239 or by phoning (941) 366-7534. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | I V Specialties Inc |
| Contact Person: | Andrew Krinsky |
| Address: | 1425 South Osprey Avenue # 1, Sarasota, Florida 34239 |
| Phone Number: | (941) 366-7534 |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 1982 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Infectious Disease Specialists |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
I V Specialties Inc was started in 1982 to provide professional Infectious Disease Specialists under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Andrew Krinsky for inquiries that concern I V Specialties Inc by calling the company number (941) 366-7534, as your correspondence is most welcome. Additionally, the physical location of the single location of I V Specialties Inc can be found at the coordinates 27.320863,-82.533634 as well as the street address 1425 South Osprey Avenue # 1 in Sarasota, Florida 34239.
For its online presence, you may visit I V Specialties Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.